This company has been acquired
Sharps Compliance Future Growth
Future criteria checks 3/6
Key information
55.0%
Earnings growth rate
52.06%
EPS growth rate
| Healthcare earnings growth | 14.1% |
| Revenue growth rate | 5.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
Aurora Capital Partners affiliate to acquire Sharps Compliance for $8.75 per share
Jul 12We Like These Underlying Return On Capital Trends At Sharps Compliance (NASDAQ:SMED)
Jul 02
Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Jun 13Sharps Compliance Corp.'s (NASDAQ:SMED) Shareholders Might Be Looking For Exit
May 25Here's Why I Think Sharps Compliance (NASDAQ:SMED) Might Deserve Your Attention Today
May 03Sharps Compliance: Update Prior To Important Earnings
Apr 26Sharps Compliance: An Operator In The Medical Waste Industry
Jan 04Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Dec 06Time To Worry? Analysts Just Downgraded Their Sharps Compliance Corp. (NASDAQ:SMED) Outlook
Aug 20These 4 Measures Indicate That Sharps Compliance (NASDAQ:SMED) Is Using Debt Reasonably Well
Jun 18With EPS Growth And More, Sharps Compliance (NASDAQ:SMED) Is Interesting
May 20Are Investors Undervaluing Sharps Compliance Corp. (NASDAQ:SMED) By 39%?
May 07What Type Of Shareholders Own The Most Number of Sharps Compliance Corp. (NASDAQ:SMED) Shares?
Mar 15Has Sharps Compliance (NASDAQ:SMED) Got What It Takes To Become A Multi-Bagger?
Mar 01Upgrade: Analysts Just Made A Substantial Increase To Their Sharps Compliance Corp. (NASDAQ:SMED) Forecasts
Feb 02Earnings Beat: Sharps Compliance Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 01Is Sharps Compliance (NASDAQ:SMED) Weighed On By Its Debt Load?
Jan 26Is There An Opportunity With Sharps Compliance Corp.'s (NASDAQ:SMED) 33% Undervaluation?
Jan 05
Don't Ignore The Fact That This Insider Just Sold Some Shares In Sharps Compliance Corp. (NASDAQ:SMED)
Dec 18Shareholders Are Thrilled That The Sharps Compliance (NASDAQ:SMED) Share Price Increased 117%
Dec 07Is Sharps Compliance Corp. (NASDAQ:SMED) Popular Amongst Insiders?
Nov 18Does Sharps Compliance (NASDAQ:SMED) Have A Healthy Balance Sheet?
Jul 24Does The Market Have A Low Tolerance For Sharps Compliance Corp.'s (NASDAQ:SMED) Mixed Fundamentals?
Jul 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 77 | 5 | 7 | 8 | 1 |
| 6/30/2023 | 65 | 1 | 2 | 4 | 2 |
| 6/30/2022 | 65 | -1 | -6 | -4 | 2 |
| 3/31/2022 | 69 | 4 | 3 | 5 | N/A |
| 12/31/2021 | 79 | 11 | 12 | 14 | N/A |
| 9/30/2021 | 77 | 12 | 15 | 17 | N/A |
| 6/30/2021 | 76 | 13 | 19 | 22 | N/A |
| 3/31/2021 | 70 | 10 | 2 | 7 | N/A |
| 12/31/2020 | 53 | 2 | -3 | 2 | N/A |
| 9/30/2020 | 51 | 1 | -3 | 2 | N/A |
| 6/30/2020 | 51 | 2 | -3 | 1 | N/A |
| 3/31/2020 | 51 | 1 | -2 | 1 | N/A |
| 12/31/2019 | 50 | 1 | -1 | 1 | N/A |
| 9/30/2019 | 48 | 1 | 0 | 1 | N/A |
| 6/30/2019 | 44 | 0 | 0 | 1 | N/A |
| 3/31/2019 | 42 | 0 | 0 | 2 | N/A |
| 12/31/2018 | 42 | 0 | 1 | 2 | N/A |
| 9/30/2018 | 41 | -1 | 1 | 2 | N/A |
| 6/30/2018 | 40 | -1 | 1 | 2 | N/A |
| 3/31/2018 | 41 | 0 | 0 | 1 | N/A |
| 12/31/2017 | 40 | 0 | -1 | 1 | N/A |
| 9/30/2017 | 38 | 0 | -1 | 1 | N/A |
| 6/30/2017 | 38 | -1 | -3 | -1 | N/A |
| 3/31/2017 | 37 | -2 | -3 | 0 | N/A |
| 12/31/2016 | 35 | -2 | -3 | 1 | N/A |
| 9/30/2016 | 35 | -1 | -3 | -1 | N/A |
| 6/30/2016 | 33 | 0 | -1 | 1 | N/A |
| 3/31/2016 | 34 | 1 | -1 | 1 | N/A |
| 12/31/2015 | 33 | 1 | N/A | 1 | N/A |
| 9/30/2015 | 32 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SMED's forecast earnings growth (55% per year) is above the savings rate (1.9%).
Earnings vs Market: SMED's earnings (55% per year) are forecast to grow faster than the US market (14.2% per year).
High Growth Earnings: SMED's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SMED's revenue (5.1% per year) is forecast to grow slower than the US market (7.7% per year).
High Growth Revenue: SMED's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SMED's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/08/24 17:51 |
| End of Day Share Price | 2022/08/22 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sharps Compliance Corp. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kevin Steinke | Barrington Research Associates, Inc. |
| null null | Burkenroad Reports |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |